MoneyWorks4Me

Glenmark Pharmaceuticals submits copy of press release

23 Oct 2015 Evaluate

Glenmark Pharmaceuticals has submitted a copy of press release dated October 23, 2015 titled ‘Glenmark announces Strategic Development & Licensing Agreement with Celon, Poland for generic Seretide Accuhaler in Europe’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1755.85
Dr. Reddys Labs. 1180.05
Cipla 1297.85
Lupin 1952.80
Zydus Lifesciences 1110.80
View more..